MAN IN DISEASE - PowerPoint PPT Presentation

1 / 29
About This Presentation
Title:

MAN IN DISEASE

Description:

... inter current infections and diffuse CNS involvement are major cause of death. ... abnormal immune tests include anti-DNA or anti-Sm (Smith) antibodies, falsely ... – PowerPoint PPT presentation

Number of Views:69
Avg rating:3.0/5.0
Slides: 30
Provided by: sm6695
Category:

less

Transcript and Presenter's Notes

Title: MAN IN DISEASE


1
  • MAN IN DISEASE
  • SYSTEMIC LUPUS ERYTHEMATOSUS
  • PRESENTED BY
  • DR SMITHA
    VELAYUDHAN

2
  • It is an inflammatory disease of autoimmune
    nature involving the connective tissue of several
    organ
  • Two forms of SLE
  • 1.Systemic or Disseminated form
  • 2.Discoid form
  • Male to female proportion is 118. More than 60
    of cases are between the ages of 30 and 60.

3
  • ETIOLOGY
  • Exact etiology unknown.
  • Genetic factors Predisposition to develop
    autoantibodies to nuclear and cytoplasmic
    antigens in SLE is due to immunoregularity
    functions of class II HLA. HLA B8 and DR3
    inherited deficiency of C1,C4,C2 complements.

4
  • Other factors are
  • Certain drug-egPenicillamin D
  • Viral infections-egEBV infections
  • Hormones-egoestrogens

5
  • PATHOLOGY
  • . Four types of histological pictures are seen.
    They are fibrinoid change, collagen sclerosis,
    formation of hematoxylin bodies and inflammatory
    changes in arterioles and capillaries. Tissue
    damage occurs in two different way
  • Direct cytotoxicity(Type 2 reaction) caused by
    antibody and complement.
  • Type 3 immune reaction caused by immune complexes
    and complement

6
  • PATHOGENESIS
  • Type 2 reaction is characterized by formation of
    autoantibodies against blood cells(Rbc,Platelets
    leucocytes) and results in haematological
    derangement in SLE
  • Type 3 reaction is characterized by an
    antigen-antibody complex which is deposited at
    sites such as renal glomeruli, walls of small
    blood vessels etc.

7
  • LE cell phenomenon
  • This was the first diagnostic laboratory test
    described for SLE.
  • LE cell is a phagocytic leucocyte, which engulfs
    the homogenous nuclear material of the injured
    cell.
  • If this mass is engulfed by a neutrophil,
    displacing the nucleus of neutrophil to the rim
    of the cell, it is called LE cell.

8
  • CLINICAL FEATURES
  • Presenting symptom is fever which may take
    several forms, from mild subacute illness to
    severe hectic fever.
  • Arthritis and arthralgia-joint manifestations
    occur in 90 of subjects with SLE in the early
    stages. Large joints are mostly affected.
    Jaccouds arthropathy may affect the hand in up
    to 50 of cases. It is characterized by
    reducible, non-erosive joint deformities with
    preservation of hand function. Permanent
    deformities do not occur.

9
  • Skin lesions- occurs in 65 of cases. Classic
    lesion is the erythematous, photosensitive
    butterfly rash affecting the cheeks and nose.
    This is diagnostic. Discoid lupus, maculopapular
    rashes and purpura may occur in some. Frontal
    baldness may develop. Alopecia, painful ulcers in
    mouth and pharynx.

10
(No Transcript)
11
  • Cardiac- occurs in 25 to 40 of cases. Lesions
    include pericarditis, pericardial effusion,
    myocarditis with cardiac failure, and valvulitis
    involving the mitral valve. Libman-sacks
    endocaritis is a non-bacterial verrrucous
    endocarditis affecting the mitral valve. It
    results in mitral incompetence.

12
  • Respiratoty Occurs in 30 of cases. Lesions are
    dry pleurisy, pleural effusion, fibrosing
    alveolitis and lupus pneumonitis. A syndrome of
    shrinking lungs is uncommon, but virtually
    pathognomonic of SLE, characterized by
    progressive reduction in lung volume with
    evidence of diaphragmatic weakness.

13
  • Kidney lesion occurs in 60 of cases. Renal
    involvement used to be the most important lesion
    deciding the prognosis. Symptoms may vary.
    Sometimes asymptomatic with only proteinuria for
    long intervals or may manifest as nephritic
    syndrome, haematuria, acute nephritic syndrome or
    renal failure.

14
  • Nervous system Lesions in about 40 of cases, is
    generally a later manifestation even though
    psychiatric symptom may occur early. Parents with
    the aniphospholipid antibodies are more prone to
    develop Stroke. Other manifestations are
    Psychoses, convulsions, cranial nerve palsies,
    peripheral neuropathy, chorea, cerebellar
    disturbances.

15
  • Muscle involvement Myalgia,polymyositis and
    muscle wasting.
  • Haematology Lesions involve normocytic
    normochromic anaemia, Coombs positive autoimmune
    haemolytic anaemia, leucopenia and
    thrombocytopenia.
  • Eyes Lesions include dryness of the conjunctiva
    and retinal abnormalities such as haemorrhage and
    exudates known as cytoid bodies.

16
  • Diagnosis of SLE may be obvious in a young
    women with a butterfly rash over the face,
    fever, pain but no deformities, one or more
    peripheral joints, pleuritic chest pain and
    photosensitivity. But in some the presentation of
    SLE is subtle and puzzling, taking form such as
    febrile illness of an unknown origin, abnormal
    urinary findings or neuropsychiatric
    manifestations including psychosis.

17
  • A variety of clinical findings point towards
    renal involvement including haematuria, red cell
    casts, proteinuria, in some cases the classic
    nephritic syndrome. Renal failure occurs,
    especially in patients with diffuse proliferative
    or membranous glomerulonephritis or both. ANAs
    can be in 100 of patients but it can be present
    in patients with other autoimmune disorder.
    Antidouble stranded DNA antibody are considered
    highly diagnostic of SLE

18
  • The cause of SLE is extremely variable. But some
    unfortunate individuals follow a progressively
    down hill course to death within months. More
    often the disease is characterized by flare-ups
    and remissions. Acute attacks are usually
    controlled by adrenocortical steroids or
    immunosuppressive drugs. Overall the 10 year
    survival rate is approximately is 70. Renal
    failure, inter current infections and diffuse CNS
    involvement are major cause of death.

19
  • LABORATORY INVESTIGATIONS
  • SLE gives rise to an array of abnormalities, some
    being specific and the other non specific. The
    non specific features include, markedly elevated
    ESR(above 100mm), moderate anaemia, leucopenia,
    thrombocytopenia and moderate to severe
    proteinuria.

20
  • DIAGNOSIS
  • The diagnosis of SLE should be suspected if there
    are febrile episodes with multisystem involvement
    high ESR, not responding to general lines of
    treatment.
  • The American Rheumatism assosciation has laid
    down criteria for diagnosis of SLE.

21
  • The 11 criteria used for diagnosing systemic
    lupus erythematosus are
  • malar (over the cheeks of the face) "butterfly"
    rash
  • discoid skin rash patchy redness that can cause
    scarring
  • photosensitivity skin rash in reaction to
    sunlight exposure
  • mucus membrane ulcers ulcers of the lining of
    the mouth, nose or throat

22
  • arthritis two or more swollen, tender joints of
    the extremities
  • pleuritis/pericarditis inflammation of the
    lining tissue around the heart or lungs, usually
    associated with chest pain with breathing
  • kidney abnormalities abnormal amounts of urine
    protein or clumps of cellular elements called
    casts

23
  • brain irritation manifested by seizures
    (convulsions) and/or psychosis
  • blood count abnormalities low counts of white or
    red blood cells, or platelets
  • immunologic disorder abnormal immune tests
    include anti-DNA or anti-Sm (Smith) antibodies,
    falsely positive blood test for syphilis,
    anticardiolipin antibodies, lupus anticoagulant,
    or positive LE prep test

24
  • antinuclear antibody positive ANA antibody
    testing
  • In addition to the 11 criteria, other tests can
    be helpful in evaluating patients with SLE to
    determine the severity of organ involvement.
    These include routine testing of the blood to
    detect inflammation (for example, a test called
    the sedimentation rate), blood chemistry testing,
    direct analysis of internal body fluids, and
    tissue biopsies. Abnormalities in body fluids and
    tissue samples (kidney, skin, and nerve biopsies)
    can further support the diagnosis of SLE.

25
  • MANAGEMENT
  • Since there is no curative measures, the main aim
    is to induce remission and prevent relapses.
    General management consists of avoidance of
    direct sunlight and offending drugs and prompt
    attention to complications.

26
MIASMATIC CLEAVAGE
  • Fundamental defect in SLE seems to be a failure
    to maintain self tolerance. As a result a wide
    array of autoantibodies that damage tissue is
    produced-SYPHILITIC
  • .Pain in joints-SYPHILITIC
  • Lupus-TRIMIASMATIC
  • Baldness-PSORA

27
  • Painful ulcers in mouth and pharynx-SYPHILIS
  • Valvular affections-PSORASYCOSIS
  • Hematuria-TUBECULAR

28
MEDICINES
  • 3-Mark remedies
  • ARS ALB,LYCO,NIT ACID,THUJA

29
  • THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com